genedrive plc (FRA:D6M)

Germany flag Germany · Delayed Price · Currency is EUR
0.0100
0.00 (0.00%)
Last updated: Dec 4, 2025, 8:07 AM CET
25.00%
Market Cap 11.49M
Revenue (ttm) 741.26K
Net Income (ttm) -8.91M
Shares Out n/a
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 200,000
Average Volume 14,415
Open 0.0100
Previous Close 0.0100
Day's Range 0.0100 - 0.0100
52-Week Range 0.0005 - 0.0305
Beta n/a
RSI 51.97
Earnings Date Nov 28, 2025

About genedrive

genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides c system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a certified test for identification of individuals unlikely to respond to the commonly prescribed antiplatelet drug Cl... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 43
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol D6M
Full Company Profile

Financial Performance

In 2024, genedrive's revenue was 501,000, an increase of 810.91% compared to the previous year's 55,000. Losses were -7.08 million, 37.4% more than in 2023.

Financial numbers in GBP Financial Statements

News

AIM Market Roundup: Genedrive, Idox, Diales

Genedrive, Idox, Diales are today's top risers, while Future Metals, Team take the biggest fall on London's AIM market

5 weeks ago - The Armchair Trader

AIM Market Roundup: Proteome Sciences, TAP Global, Various Eateries

Proteome Sciences, TAP Global, Various Eateries are today's top risers, while Arc Minerals, Genedrive take the biggest fall on London's AIM

6 weeks ago - The Armchair Trader